IRulya Therapeutics Inc.
IRLA· Nasdaq
IRLAIRulya Therapeutics Inc.
Filed Jun 12, 2019 · 10-Q · 73 days after period end · 0001564590-19-022340
| Metric | Q1 2019 | Q1 2018 |
|---|---|---|
| Net Income | -$5.68M | -$3.38M |
| EPS Diluted | -$1.61 | -$1.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IRulya Therapeutics Inc. · CIK 1662774 · Engraved from SEC EDGAR
ended Mar 31, 2019 · filed Jun 12, 2019 · 73 d after period end
